Thirty years of treating HIV-1 infection: where next? by Frater, A

Advancing the HIV cure agenda: the next 5 years. by Thornhill, J, Fidler, S, Frater, A

HIV-1 resistance genotyping by sequencing produces inconsistent results for mixed viral populations. by Frater, A, Chaput, C, Weber, J, McClure, M

Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell–mediated control of HIV-1, HCV, and HTLV-1 by Boelen, L, Debebe, B, Silveira, M, Frater, A, al., E

Simple detection of point mutations associated with HIV-1 drug resistance. by Frater, A, Chaput, C, Beddows, S, Weber, J, McClure, M

Low copy target detection by droplet digital PCR through application of a novel open access bioinformatic pipeline, ‘definetherain’ by Jones, M, Williams, J, Gartner, K, Phillips, R, Hurst, J, Frater, A

Baseline polymorphisms found in patients infected with non-clade BHIV-1 do not affect outcome to HAART by Frater, A, Galpin, S, Beardall, A, Clarke, JR, Ariyoshi, K, Weber, J, McClure, M

Longitudinal analysis of an HLA-B*51-restricted epitope in integrase reveals immune escape in early HIV-1 infection. by Yager, N, Robinson, N, Brown, H, Flanagan, P, Frater, A, Fidler, S, Weber, J, Phillips, R

Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy. by Frater, A, Dunn, D, Beardall, A, Ariyoshi, K, Clarke, JR, McClure, M, Weber, J

Systemic gene transfer of oxidant stress genes and blood pressure in a model of genetic hypertension by Miller, W, Graham, D, Brosnan, M, Frater, A, Channon, K, Reynolds, P, Baker, A, Dominiczak, A

Adenoviral-mediated systemic administration of candidate therapeutic genes in a model of genetic hypertension by Miller, W, Brosnan, M, Graham, D, Frater, A, Channon, K, Reynolds, P, Baker, A, Dominiczak, A

Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients. by Frater, A, Beardall, A, Ariyoshi, K, Churchill, D, Galpin, S, Clarke, JR, Weber, J, McClure, M

Endothelial targeting of adenoviral vectors expressing eNOS lowers blood pressure in a rat model of genetic hypertension by Miller, W, Brosnan, M, Graham, D, Frater, A, Channon, K, Reynolds, P, Baker, A, Dominiczak, A

Targeted delivery of adenovirus expressing eNOS to the endothelium in vivo lowers blood pressure in hypertensive rats by Miller, W, Brosnan, M, Graham, D, Frater, A, Channon, K, Danilov, S, Reynolds, P, Baker, A, Dominiczak, A

High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse by Duncan, C, Williams, J, Schiffner, T, Gärtner, K, Ochsenbauer, C, Kappes, J, Russell, R, Frater, A, Sattentau, Q

Differential susceptibility of retroviruses to nucleoside analogues. by Rosenblum, L, Patton, G, Grigg, A, Frater, A, Cain, D, Erlwein, O, Hill, C, Clarke, JR, McClure, M

HIV-1 Specific CD4 Responses in Primary HIV-1 Infection predict disease progression in the SPARTAC Trial by Frater, A, Ewings, F, Hurst, J, Brown, H, Robinson, N, Fidler, S, Babiker, A, Weber, J, Porter, K, Phillips, R

Performance of two commercially available sequence-based HIV-1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes. by Beddows, S, Galpin, S, Kazmi, S, Ashraf, A, Johargy, A, Frater, A, White, N, Braganza, R, Clarke, J, McClure, M, Weber, J

Tenofovir disoproxil fumarate fails to prevent HIV acquisition or the establishment of a viral reservoir: two case reports by Fox, J, Brady, M, Alexander, H, Davies, O, Robinson, N, Pace, M, Else, L, Cason, J, Khoo, S, Back, D, Fidler, S, Frater, A

Mutagenically separated PCR assay for rapid detection of M41L and K70R zidovudine resistance mutations in CRF01_AE (subtype E) human immunodeficiency virus type 1. by Myint, L, Ariyoshi, K, Yan, H, Frater, A, Auwanit, W, Pathipvanith, P, Yamada, K, Matsuda, M, Chiba, T, Fujita, K, McClure, M, Weber, J, Sugiura, W